Cleared Traditional

K232007 - CAAS MR Solutions

K232007 is the FDA 510(k) clearance for CAAS MR Solutions by Pie Medical Imaging BV. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 210-day FDA review.

K232007 · Pie Medical Imaging BV · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2024
Decision
210d
Days
Class 2
Risk

K232007 is an FDA 510(k) clearance for the CAAS MR Solutions. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Pie Medical Imaging BV (Maastricht, NL). The FDA issued a Cleared decision on February 1, 2024 after a review of 210 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Pie Medical Imaging BV devices

Submission Details

510(k) Number K232007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 2023
Decision Date February 01, 2024
Days to Decision 210 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 107d · This submission: 210d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K232007.
Autofuse
K233572 · Pymedix · Mar 2024
Mimics Cardiac Planner
K233217 · Materialise NV · Feb 2024
Aid-U
K231662 · Iaid · Feb 2024
Augmented Reality Application
K232339 · Sira Medical, Inc. · Feb 2024
CEPHX- Cephalometric Analysis Software
K231396 · Orca Dental AI , Ltd. · Jan 2024
BreView
K233714 · GE Medical Systems SCS · Jan 2024